Zyban and smoking cessation: predictors of success

P. Panagou, V. Grammenou, S. Tsipra, D. Poulou, I. Pappa, K. Kostikas, K. Tsintiris, S. Loukides (Athens, Greece)

Source: Annual Congress 2003 - Smoking cessation with focus on predictors
Session: Smoking cessation with focus on predictors
Session type: Thematic Poster Session
Number: 843
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Panagou, V. Grammenou, S. Tsipra, D. Poulou, I. Pappa, K. Kostikas, K. Tsintiris, S. Loukides (Athens, Greece). Zyban and smoking cessation: predictors of success. Eur Respir J 2003; 22: Suppl. 45, 843

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors affecting the success of smoking cessation treatment in a smoking cessation clinic
Source: International Congress 2017 – Smoking cessation
Year: 2017

Smoking cessation and bupropion: predictive factors of success therapy
Source: Annual Congress 2003 - Smoking cessation
Year: 2003


Abstinence rates and predictors of outcome for smoking cessation
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Predictors of smoking cessation
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Relapse rates following different types of medication treatment through a smoking cessation program
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


The success rate of a smoking cessation programme in patients attempted to quit smoking
Source: Eur Respir J 2002; 20: Suppl. 38, 133s
Year: 2002

Electronic cigarettes for smoking cessation: an opportunity to readdress smoking cessation treatment
Source: Eur Respir J, 56 (4) 2000098; 10.1183/13993003.00098-2020
Year: 2020



Success rates of smoking cessation program using bupropion therapy: a 1-year experience
Source: Eur Respir J 2005; 26: Suppl. 49, 388s
Year: 2005

Smoking cessation according to nicotine dependence: experience of a smoking cessation program
Source: Virtual Congress 2020 – From tobacco control policy to smoking cessation
Year: 2020


Factors associated with abstinence and effectiveness of a smoking cessation program
Source: Eur Respir J 2006; 28: Suppl. 50, 390s
Year: 2006

Clinical and pathological determinants of abstinence rate in smoking cessation with varenicline
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010

Smoking cessation success according to anxiety levels: experience of a smoking cessation program
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019

Smoking cessation: can we obtain more than we do at present?
Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke?
Year: 2006


Predicting factors for the success of smoking cessation
Source: Eur Respir J 2005; 26: Suppl. 49, 389s
Year: 2005

Quitting smoking: the benefits
Source: Breathe, 13 (3) 263; 10.1183/20734735.ELF133
Year: 2017



Causes of quitting treatment with varenicline in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009

Nonpharmacological smoking cessation interventions in clinical practice
Source: Eur Respir Rev 2008; 17: 187-191
Year: 2008



e-cigarettes for smoking cessation
Source: International Congress 2015 – E-cigarettes: a wolf in sheep's clothing or a sheep in wolf's clothing?
Year: 2015